Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

SELECT MEDICAL HOLDINGS CORP

Changes in Beneficial Ownership

Filed Jul 1, 2026Accepted Jul 1, 2026, 2:19 PM EDTFiling CIK 1320414Accession 0001169897-26-000003
Share

Structured filing — 4

form4-07012026_060755.xml

Open full document ↗

Filing details

Report period
2026-06-30
Issuer
SELECT MEDICAL HOLDINGS CORP
Issuer CIK
0001320414
Trading symbol
SEM
No longer subject to Section 16
Checked

Reporting owner 1

Name
CHERNOW DAVID S
Reporting owner CIK
0001169897
Relationship
Director · Officer
Officer title
VICE CHAIRMAN
Address
C/O SELECT MEDICAL HOLDINGS CORPORATION, 4714 GETTYSBURG ROAD, MECHANICSBURG, PA, 17055

Non-derivative transactions

Non-derivative transactions · 3 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-06-30J · Form 4[F1]100,000[F2]D0777,244D
Common Stock2026-06-30D · Form 4[F1]656,823[F3]D16.50113,421D
Common Stock2026-06-30F · Form 4[F4]113,421D16.500D
Table key
J · Form 4
Other acquisition or disposition; see explanation
D
Direct
D · Form 4
Disposition to the issuer under Rule 16b-3(e)
F · Form 4
Securities delivered or withheld for exercise price or tax liability under Rule 16b-3

Footnotes

F1
This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).↩ 1↩ 2
F2
Immediately prior to the effective time of the merger, the Reporting Person contributed 100,000 restricted shares to Parent in exchange for an equivalent amount of restricted shares of Parent, which restricted shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.↩ 1
F3
At the effective time of the merger, each of the Reporting Person's shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").↩ 1
F4
Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.↩ 1

Signature 1

Signed
/s/ John F. Duggan, Attorney-in-Fact
Date
2026-07-01

Company context

Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on number of facilities. Select Medical’s reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, and the outpatient rehabilitation segment. As of March 31, 2026, Select Medical operated 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics in 37 states and the District of Columbia. At March 31, 2026, Select Medical had operations in 38 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

Historical securities (1)

Recent company filings

  1. SCHEDULE 13G/A - filed by VANGUARD PORTFOLIO MANAGEMENT LLC regarding SELECT MEDICAL HOLDINGS CORPJul 31, 2026
  2. 15-12G filingJul 13, 2026
  3. 4 filingJul 1, 2026
  4. 4 filingJul 1, 2026
  5. 4 filingJul 1, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.